Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
718studies shown
Showing 97-108 of 718
Drug study icon
RecruitingNCT05304767

Safety study of KarXT in schizophrenia

This study is recruiting in the United States, in the United Kingdom, in Bulgaria, .... It is testing KarXT for schizophrenia.

Multiple locations, including Phoenix
SchizophreniaOtherFrom 18 Years to 65 Years
Countries
United States, United Kingdom, Bulgaria, ...
Sponsor
Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Condition
Schizophrenia
Other study type icon
RecruitingNCT05823532

Anti-Inflammatory Challenge in Schizophrenia

This study is recruiting. It focuses on schizophrenia and currently lists participation information in the United States.

In Atlanta
SchizophreniaOtherFrom 18 Years to 55 Years
Countries
United States
Sponsor
Emory University
Condition
Schizophrenia
Other study type icon
RecruitingNCT06562608

Anticholinergic Deprescription in Schizophrenia

This study is recruiting. It focuses on schizophrenia and currently lists participation information in the United States.

In Pittsburgh
SchizophreniaOtherFrom 40 Years to 70 Years
Countries
United States
Sponsor
Deepak K. Sarpal, M.D.
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.